Doctor profile · Federal record
Dr. Davida Krupnick, M.D.
Dermatology Physician (CMS: Dermatology) · Philadelphia, PA
- NPI 1942593462
- Accepts Medicare
- MIPS 79.6 / 100 · 2023
- 15 yrs in practice
- Female
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
1930 S Broad St Ste 21
Philadelphia, PA 191452328
(215) 463-3939
Credentials & registration
- NPI registered
- May 2011 — 15 yrs on file
- Profile last updated
- September 1, 2020
- Year of graduation
- 2011 — 15 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- Pennsylvania #MD464425
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1942593462. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
2,439
Distinct HCPCS
10
Medicare allowed
$163,757
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 750 | 126 | $7 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 348 | 253 | $94 | |
11102 |
Biopsy of related skin growth, first growth | 223 | 174 | $98 | |
17000 |
Destruction of precancer skin growth, 1 growth | 215 | 162 | $51 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 194 | 105 | $132 | |
17110 |
Destruction of skin growth, 1-14 growths | 148 | 121 | $117 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 132 | 132 | $117 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 86 | 68 | $58 | |
11103 |
Biopsy of related skin growth, each additional growth | 78 | 52 | $53 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 58 | 21 | $1 |
In context: peer comparison
Among 55 peers in this city , average services per provider: 169. This provider delivers 14× the peer median.Open Payments
Industry payments received
All-time total
$2,244
Transactions
123
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ABBVIE INC. | 30 | $515.12 | |
| Janssen Biotech, Inc. | 20 | $327.70 | |
| E.R. Squibb & Sons, L.L.C. | 9 | $182.15 | |
| Arcutis Biotherapeutics, Inc. | 10 | $166.30 | |
| Lilly USA, LLC | 8 | $161.18 | |
| LEO Pharma Inc. | 11 | $155.83 | |
| Dermavant Sciences, Inc. | 11 | $150.86 | |
| GENZYME CORPORATION | 4 | $103.47 | |
| Incyte Corporation | 4 | $91.29 | |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $82.78 | |
| Regeneron Healthcare Solutions, Inc. | 3 | $78.88 | |
| UCB, Inc. | 4 | $76.41 | |
| Galderma Laboratories, L.P. | 4 | $67.22 | |
| Amgen Inc. | 1 | $34.62 | |
| Novartis Pharmaceuticals Corporation | 1 | $30.23 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,464
Patients
838
Total drug cost
$212,762
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Triamcinolone Acetonide | Generic | 273 | 182 | $3,442 |
| Ketoconazole | Generic | 245 | 122 | $4,787 |
| Clobetasol Propionate | Generic | 157 | 97 | $7,883 |
| Hydrocortisone | Generic | 157 | 99 | $885 |
| Fluocinonide | Generic | 131 | 74 | $5,596 |
| Clindamycin Phosphate | Generic | 77 | 32 | $4,227 |
| Doxycycline Hyclate | Generic | 67 | 49 | $1,324 |
| Mupirocin | Generic | 67 | 49 | $603 |
| Betamethasone Dipropionate | Generic | 60 | 20 | $4,691 |
| Ammonium Lactate | Generic | 48 | 30 | $1,069 |
Frequently asked questions
What is Dr. Davida Krupnick's medical specialty?
Dr. Davida Krupnick practices Dermatology Physician in Philadelphia, PA.
Where does Dr. Davida Krupnick practice?
Dr. Davida Krupnick practices at 1930 S Broad St Ste 21, Philadelphia, PA 191452328. Office phone: 2154633939.
What is Dr. Davida Krupnick's NPI?
Dr. Davida Krupnick's National Provider Identifier (NPI) is 1942593462, issued by NPPES.
Does Dr. Davida Krupnick accept Medicare assignment?
Yes. Dr. Davida Krupnick accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Davida Krupnick commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Biopsy of related skin growth, first growth (HCPCS 11102). Source: CMS Medicare Physician & Other Practitioners file.